Center for Epidemiologic Studies Depression Scale

1. Abstract

The Center for Epidemiologic Studies Depression Scale (CES-D) represents a foundational milestone in psychiatric epidemiology and quantitative psychological assessment. Originally developed by Lenore Sawyer Radloff at the National Institute of Mental Health (NIMH) in 1977, the instrument was engineered specifically to assess the frequency and severity of depressive symptomatology in non-institutionalized general population samples, distinguishing itself from clinical diagnostic inventories designed primarily for psychiatric inpatient tracking. The scale comprises 20 self-report items evaluated on a 4-point Likert-type frequency metric ranging from 0 (“Rarely or none of the time / less than 1 day”) to 3 (“Most or all of the time / 5–7 days”), referencing symptom occurrences during the preceding seven days. Across diverse demographic strata and age groups, the CES-D captures a robust multidimensional operationalization of depression, traditionally fractionated into four primary subscales or latent factors: Depressed Affect, Positive Affect (anhedonia/well-being), Somatic and Retarded Activity, and Interpersonal Difficulties. Psychometric evaluations across international epidemiological studies have repeatedly documented high internal consistency, with Cronbach’s alpha coefficients typically spanning .85 to .90 in community cohorts and exceeding .90 in clinical populations. Convergent validity is confirmed by substantial correlations with clinician-administered instruments—such as the Hamilton Rating Scale for Depression (HRSD) and the Raskin Depression Rating Scale—as well as self-administered scales like the Bradburn Negative Affect Scale and the Lubin Depression Adjective Check Lists. Demonstrating an optimal balance between sensitivity to acute environmental changes and underlying structural stability across sex, age, and cultural groups, the CES-D remains one of the gold-standard screening tools in behavioral medicine, public health surveys, and longitudinal neuropsychiatric research.

2. Keywords

Center for Epidemiologic Studies Depression Scale, CES-D, depressive symptomatology, psychiatric epidemiology, psychometric evaluation, affective disorders, negative affect, screening instrument, public health assessment, factor structure, internal consistency, self-report inventory

3. Authors

The Center for Epidemiologic Studies Depression Scale was formulated by Lenore Sawyer Radloff, M.A., during her tenure as a research psychologist at the Center for Epidemiologic Studies within the Division of Biometry and Epidemiology at the National Institute of Mental Health (NIMH), United States Department of Health and Human Services, Bethesda, Maryland. Radloff collaborated closely with distinguished epidemiologists and methodologists, including George W. Comstock and Donald S. Rae, in executing extensive community trials across Maryland and Missouri to calibrate and cross-validate the psychometric properties of the instrument.

4. Purpose

Prior to the introduction of the CES-D in 1977, the vast majority of psychological depression inventories were developed in psychiatric settings. Instruments such as the Beck Depression Inventory (BDI; Beck et al., 1961) and the Zung Self-Rating Depression Scale (SDS; Zung, 1965) were explicitly configured to assess the severity of illness among diagnosed clinical populations or to track therapeutic response during clinical drug trials. Consequently, these instruments exhibited psychometric features that were ill-suited for large-scale epidemiological field research: they were often overly burdensome, laden with dense somatic items that could confound physical illness with affective pathology in general populations, or overly reliant on clinical jargon requiring professional administration.

The overarching purpose of the CES-D was to provide a brief, reliable, and valid metric that lay interviewers could administer smoothly in household surveys without psychiatric training. The instrument was intentionally engineered not as a definitive diagnostic instrument for Major Depressive Disorder (MDD)—which requires formal clinical evaluation according to criteria such as the DSM or ICD—but rather as a sensitive epidemiological surveillance tool. Its primary utility lies in identifying individuals who exhibit clinically significant levels of depressive distress and in measuring symptom variance across the continuum from normal affective fluctuations to severe mood disruption.

In public health contexts, the CES-D enables researchers to quantify the prevalence and incidence of depressive symptomatology, examine associations between affective distress and social determinants of health (such as socioeconomic status, marital disruption, and racial disparities), and investigate the psychological consequences of acute life stressors and chronic somatic disease. In behavioral medicine and clinical research, the CES-D serves as a secondary screening mechanism to monitor trajectories of psychological distress, explore bidirectional interactions with conditions such as cardiovascular disease, diabetes, and oncology, and evaluate community-level interventions.

5. Psychological Construct

The construct operationalized by the CES-D is current depressive symptomatology, specifically conceptualized as a multi-faceted state characterized by affective, cognitive, somatic, and interpersonal dysregulation. Grounded in clinical observations and empirical factor analyses of depression symptom pools, the CES-D reflects a hierarchical paradigm where a general depressive dimension subsumes four intercorrelated second-order components:

• Depressed Affect (Dysphoric Mood): This core dimension captures primary emotional suffering, cognitive despondency, and emotional pain. Items operationalizing this dimension assess feelings of profound sadness (Item 18: “I felt sad”), persistent crying spells (Item 17: “I had crying spells”), loneliness (Item 14: “I felt lonely”), generalized dysphoria (Item 6: “I felt depressed”), and fearfulness (Item 10: “I felt fearful”). This subscale measures the subjective emotional experience of melancholy and psychological vulnerability.
• Positive Affect / Anhedonia: In contrast to models viewing depression purely as the presence of negative affect, the CES-D includes an explicit dimension capturing the depletion of positive affectivity, subjective vitality, and pleasure. Items assessing this construct include feeling hopeful about the future (Item 8), experiencing happiness (Item 12), enjoying life (Item 16), and maintaining self-esteem or self-worth relative to others (Item 4: “I felt that I was just as good as other people”). When reverse-scored, these items quantify the severity of anhedonia, which is recognized as a cardinal diagnostic indicator of mood pathology.
• Somatic and Retarded Activity: This dimension measures the vegetative, psychomotor, and somatic manifestations that accompany depressive episodes. It indexes diminished biological vitality, motor sluggishness, and fatigue. Concrete manifestations include sleep disturbance (Item 11: “My sleep was restless”), appetite loss (Item 2: “I did not feel like eating; my appetite was poor”), subjective sense of overwhelming effort required to complete routine daily activities (Item 7: “I felt that everything I did was an effort”), psychomotor inhibition (Item 20: “I could not get ‘going'”), reduced verbal output (Item 13: “I talked less than usual”), difficulty with cognitive concentration (Item 5: “I had trouble keeping my mind on what I was doing”), and generalized non-specific irritability (Item 1: “I was bothered by things that usually don’t bother me”).
• Interpersonal Difficulties: Reflecting the relational disturbances characteristic of depressive states, this facet isolates social alienation, perceived interpersonal friction, and feelings of social rejection. The dimension is operationalized through statements reflecting subjective hostility or unwelcoming social environments (Item 15: “People were unfriendly”) and perceived interpersonal rejection (Item 19: “I felt that people dislike me”).

6. Theoretical Framework

The CES-D is rooted in the cognitive, affective, and behavioral traditions that emerged in clinical psychology during the mid-20th century. At its conceptual foundation is the proposition articulated by Aaron T. Beck, which posits that depressive disorders manifest through interrelated alterations across affective, cognitive, behavioral, and physiological systems. Beck’s cognitive triad asserts that depressive states involve systematic negative distortions regarding the self, the ongoing world/experience, and the future. This theoretical perspective directly underlies CES-D items tapping perceived failure (Item 9), subjective inadequacy, and hopelessness (Item 8).

Simultaneously, the scale is theoretically situated within the dimensional framework of affectivity articulated by Bradburn (1969), who demonstrated that psychological well-being is not simply the mirror opposite of psychological distress, but rather the resultant balance between two independent dimensions: positive affect and negative affect. Radloff incorporated this dual-axis conceptualization by including four reverse-scored items that assess positive affective engagement. This architecture ensures that the instrument measures both the presence of distressing symptoms and the absence of positive emotional resources.

Furthermore, the CES-D incorporates a continuum model of psychopathology, aligned with the epidemiological principles of Dohrenwend and Dohrenwend. Rather than treating depression as a categorical, all-or-none medical illness, the CES-D treats depressive affect as a continuously distributed variable within human populations. The theoretical premise holds that subclinical distress, situational grief, and clinically severe depressive episodes share common symptom features that vary primarily along axes of frequency, duration, and intensity. By anchoring the measurement window to the past week, the scale provides a dynamic operationalization of state-level psychological equilibrium, reflecting both intrinsic vulnerability and acute reactions to environmental and psychosocial stressors.

7. Validity

The empirical validation of the CES-D involved comprehensive testing across multiple large-scale community surveys and psychiatric samples:

• Content Validity: Content validity was established through systematic extraction of items from proven clinical depression assessment instruments, including Beck’s Depression Inventory, Zung’s Self-Rating Depression Scale, the Raskin Depression Rating Scale, and the Minnesota Multiphasic Personality Inventory (MMPI) depression subscales. An expert panel curated items to ensure comprehensive coverage of affective, cognitive, motivational, and vegetative domains while excluding clinical jargon.
• Construct Validity: Construct validity was verified by evaluating score distributions across divergent groups. In general household samples from Kansas City (N = 1,173) and Washington County (N = 1,673), CES-D scores demonstrated marked positive skewness, with over 80% of respondents scoring below the threshold of 16, yielding sample means between 7.9 and 9.2 (SD ≈ 7.5 to 8.6). Conversely, psychiatric inpatient cohorts (N = 70 and N = 35) exhibited symmetrical score distributions centered at significantly higher mean levels (mean = 24.42, SD = 13.49; and mean = 39.11, SD = 10.97, respectively). The scale also successfully tracked clinical improvement: psychiatric patients re-assessed following clinical intervention demonstrated marked score reductions that mirrored clinician-observed recovery.
• Convergent Validity: In community and clinical cohorts, the CES-D correlates substantially with established indices of negative affectivity and depression: Lubin’s Depression Adjective Check Lists (r = .51 to .60), Bradburn’s Negative Affect Scale (r = .55 to .63), and the Langner 22-Item Screening Score (r = .53 to .61). When evaluated against clinician-rated measures in inpatient groups, the CES-D exhibited strong convergent correlations with the Hamilton Rating Scale for Depression (r = .44 to .69) and the Raskin Depression Scale (r = .56 to .79).
• Discriminant Validity: Discriminant validity was demonstrated by low-to-moderate correlations with Bradburn’s Positive Affect Scale (r = -.21 to -.36) and negligible associations with measures of social desirability (Crowne-Marlowe Social Desirability Scale, r = -.18 to -.24), confirming that the instrument captures clinical mood disruption rather than generalized reporting bias or impression management.

8. Reliability

The reliability of the CES-D has been demonstrated across diverse racial, demographic, and clinical groups:

• Internal Consistency: In the initial validation studies by Radloff (1977), internal consistency reliability was assessed using Cronbach’s alpha and Spearman-Brown split-half coefficients. In the primary general population probability samples, Cronbach’s alpha reached .85 (Kansas City) and .85 (Washington County). In psychiatric clinical samples, alpha was even higher, at .90. Item-total correlations predominantly ranged between .40 and .70, demonstrating that the individual items contribute cohesively to the overarching depression construct. Subsequent international investigations across adolescents, working-age adults, and geriatric populations have confirmed alpha estimates ranging from .84 to .92.
• Test-Retest Reliability: Because the CES-D is specifically calibrated as a state-like metric measuring symptom frequency over the past week, test-retest reliability estimates reflect both measurement precision and true temporal fluctuations in mood. Radloff observed test-retest correlations of .51 to .67 over intervals of two to eight weeks, and .32 to .54 over longer intervals of 3 to 12 months in community surveys. Higher stability coefficients (r ≈ .70) were documented over short intervals (e.g., 24–48 hours), confirming that while the instrument reliably measures current psychological distress, it remains sensitive to situational changes and clinical recovery over time.

9. Factor Analysis

The structural dimensionality of the CES-D was evaluated through exploratory factor analysis (EFA) with principal component extraction and varimax rotation across multiple independent community samples (Kansas City, Washington County I, Washington County II) and psychiatric patient groups (Radloff, 1977). In these analyses, an invariant 4-factor solution emerged, explaining approximately 48% to 54% of the total scale variance:

• Factor 1: Depressed Affect: Encompassing items 3, 6, 9, 10, 14, 17, and 18, this factor displays substantial primary factor loadings (ranging from .56 to .78). It captures dysphoria, crying, loneliness, sadness, and perceived failure.
• Factor 2: Positive Affect (Reverse-Scored): Comprising items 4, 8, 12, and 16, with factor loadings ranging from .62 to .81. The separation of these items into an independent factor demonstrates that positive affectivity functions as a distinct psychometric dimension rather than merely the negative pole of dysphoria.
• Factor 3: Somatic and Retarded Activity: Loading items 1, 2, 5, 7, 11, 13, and 20 (loadings ranging from .42 to .74). This factor captures functional impairment, fatigue, sleep disturbances, appetite changes, and cognitive slowing.
• Factor 4: Interpersonal Difficulties: Distinctly isolated by items 15 (“People were unfriendly”) and 19 (“I felt that people dislike me”), displaying high factor loadings (.73 to .83) with minimal cross-loadings on other factors.

Subsequent confirmatory factor analysis (CFA) studies across diverse cultural, gender, and age cohorts have supported this original four-factor first-order model, typically nested within a second-order general depression factor. Model fit indices across large community datasets frequently show satisfactory fit (CFI > .92, TLI > .91, RMSEA < .06), supporting structural invariance across men and women and across diverse adult age groups.

10. Instrument / Measurement Tool

• Test Type: Standardized self-report symptom rating scale; suitable for self-administration, paper-and-pencil completion, digital interface, or administration by trained lay interviewers.
• Target Population: General population, adult community samples, primary care patients, and psychiatric clinical populations. Validated for individuals aged 18 years and older (with adaptations available for adolescents).
• Item Count: 20 items.
• Administration Time: Approximately 3 to 5 minutes.
• Time Frame / Recall Window: Symptoms experienced during the past week (“During the past week…”).
• Response Scale: 20 items, 4-point frequency scale (0 to 3), coded as:
  • 0 = Rarely or none of the time (less than 1 day)
  • 1 = Some or a little of the time (1–2 days)
  • 2 = Occasionally or a moderate amount of time (3–4 days)
  • 3 = Most or all of the time (5–7 days)
• Reverse-Scored Items: Items 4, 8, 12, and 16 are positively worded and reverse-scored prior to calculating the total score: (0 = 3, 1 = 2, 2 = 1, 3 = 0).
• Total Score Calculation: The sum of all 20 items (after reverse-scoring items 4, 8, 12, and 16) produces a composite score ranging from 0 to 60.
• Clinical Cutoff & Interpretation:
  • 0–15: Subclinical or minimal depressive symptomatology.
  • 16–21: Mild to moderate depressive symptoms; suggestive of meaningful psychological distress requiring clinical attention or follow-up.
  • 22–60: Severe depressive symptomatology; high probability of major affective disruption.
  • Standard Epidemiological Threshold: A cutoff score of ≥ 16 is widely used in community studies to identify individuals at elevated risk for clinical depression, demonstrating a sensitivity of roughly 80% and specificity of approximately 75% for major depressive episodes.

11. Permissions & Fee and Test Year

Publication Year: 1977.

Copyright and Accessibility: The CES-D was developed under research contracts sponsored by the National Institute of Mental Health, an agency of the United States federal government. Consequently, the original instrument is in the public domain and may be reproduced, administered, and translated without royalty fees for academic, clinical, and non-commercial research purposes.

Commercial Use: Commercial publishers or corporate entities seeking reproduction within proprietary test packages or commercial assessments must secure standard licensing clearances or process reproduction fees via the Copyright Clearance Center in accordance with fair use guidelines and publisher agreements associated with the original 1977 publication in Applied Psychological Measurement.

12. References

• Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4(6), 561–571. https://doi.org/10.1001/archpsyc.1961.01710120031004
• Bradburn, N. M. (1969). The structure of psychological well-being. Aldine Publishing Company.
• Comstock, G. W., & Helsing, K. J. (1976). Symptoms of depression in two communities. Psychological Medicine, 6(4), 551–563. https://doi.org/10.1017/s003329170001817x
• Crowne, D. P., & Marlowe, D. (1960). A new scale of social desirability independent of psychopathology. Journal of Consulting Psychology, 24(4), 349–354. https://doi.org/10.1037/h0047358
• Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23(1), 56–62. https://doi.org/10.1136/jnnp.23.1.56
• Langner, T. S. (1962). A twenty-two item screening score of psychiatric symptoms indicating impairment. Journal of Health and Human Behavior, 3(4), 269–276. https://doi.org/10.2307/2948599
• Lubin, B. (1965). Adjective check lists for measurement of depression. Archives of General Psychiatry, 12(1), 57–62. https://doi.org/10.1001/archpsyc.1965.01720310059007
• Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/10.1177/014662167700100306
• Raskin, A., Schulterbrandt, J., Reatig, N., & McKeon, J. J. (1969). Replication of factors of psychopathology in interview, ward behavior and self-report ratings of hospitalized depressives. The Journal of Nervous and Mental Disease, 148(1), 87–98. https://doi.org/10.1097/00005053-196901000-00010
• Weissman, M. M., Sholomskas, D., Pottenger, M., Prusoff, B. A., & Locke, B. Z. (1977). Assessing depressive symptoms in five psychiatric populations: A validation study. American Journal of Epidemiology, 106(3), 203–214. https://doi.org/10.1093/oxfordjournals.aje.a112455
• Zung, W. W. (1965). A self-rating depression scale. Archives of General Psychiatry, 12(1), 63–70. https://doi.org/10.1001/archpsyc.1965.01720310065008

13. Items of the Scale (Questionnaire)